MUSTANG BIO, INC. Other Current Liabilities
MUSTANG BIO, INC. (MBIO) had Other Current Liabilities of $2.54 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Current $2.54M.
- 2026-03-31: Other Liabilities, Current $2.52M.
- 2025-12-31: Other Liabilities, Current $2.50M.
- 2025-09-30: Other Liabilities, Current $2.53M.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $2.54M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $2.52M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $2.50M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $2.53M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.50M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $2.81M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.67M 10-K · filed 2026-03-19 |
| 2024-09-30 | $2.54M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.30M 10-Q · filed 2024-08-13 |
| 2023-12-31 | $834.00K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |